Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

On 11 November 2015, there was an open day at the John Radcliffe Hospital for brain tumour patients and carers. The aim was to show what clinical researchers in Oxford are doing to improve diagnosis and care. The event was organised in partnership between the Nuffield Department of Clinical Neurosciences and the Cancer Research UK Oxford Centre, and was supported by the NIHR Oxford Biomedical Research Centre and the Brain Tumour Charity.

These sorts of events help to demystify medicine and I hope there'll be more of them. - Event attendee

Fifty people of a wide range of ages attended the day, which included tours of the Neuropathology Lab and the Oxford Centre for Functional MRI of the brain. Visitors had the chance to look down a microscope and discover how tissue is prepared for analysis, as well as talking to a neurosurgeon about how he performs operations, and seeing an MRI scanner in action.

This event built on a previous open day on 13 March 2015, when we gave 80 people ranging in age from 17 to 70 a tour of the facility. After an introductory talk about the importance of having a brain bank, attendees were divided into four groups for a laboratory tour, during which they had the opportunity to look down a microscope at a healthy and diseased human brain; see a real human brain; observe how tissue is prepared for analysis; and learn about research projects involving brain bank tissue.

Similar stories

Capturing immune cells that colonise the brain to prevent disease progression in multiple sclerosis

Clinical Neurology Research

Researchers have revealed a disease-causing population of immune cells, which travel to the brain in patients with multiple sclerosis. They demonstrate how to trap these cells in the blood, which means they can be targeted to prevent disease progression.

Two neurologists awarded MRC Senior Clinical Fellowships

Clinical Neurology Research

Two of our Associate Professors, Sarosh Irani and George Tofaris, have been awarded MRC Senior Clinical Fellowships.

Developing diagnostics for COVID-19

Clinical Neurology Coronavirus Research

Associate Professor Sarosh Irani, who heads up our Autoimmune Neurology Group, has been funded by Mologic to help develop diagnostics for COVID-19.

COVID-19 and Guillain-Barré syndrome

Clinical Neurology Coronavirus Research

Multiple recent case reports have suggested a link between COVID-19 and Guillain-Barré syndrome (GBS), an acute, disabling, immune-mediated disorder of the peripheral nervous system. It is currently unclear whether this simply represents a chance association.

Viruses shown to evolve as a result of different immune responses in different ethnic populations

Clinical Neurology Coronavirus Research

New research into the HIV-1 virus has shed light on an important factor in the evolution of viruses, which is likely also to affect SARS-CoV-2 (the virus which causes COVID-19). This new insight could have important implications for vaccine development.

Emerging Leaders Prize celebrates outstanding pain researchers

Award Clinical Neurology

2020’s Emerging Leaders Prize awards £200,000 to outstanding scientists from the University of Oxford, University College London and King’s College London, who are all working in the field of pain research.